Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et)

DOI record: { "DOI": "10.3389/fmed.2022.991873", "ISSN": [ "2296-858X" ], "URL": "http://dx.doi.org/10.3389/fmed.2022.991873", "abstract": "<jats:sec><jats:title>Background</jats:title><jats:p>It has been proposed that polyphenols can be used in the development of new therapies against COVID-19, given their ability to interfere with the adsorption and entrance processes of the virus, thus disrupting viral replication. Seeds from <jats:italic>Caesalpinia spinosa</jats:italic>, have been traditionally used for the treatment of inflammatory pathologies and respiratory diseases. Our team has obtained an extract called P2Et, rich in polyphenols derived from gallic acid with significant antioxidant activity, and the ability to induce complete autophagy in tumor cells and reduce the systemic inflammatory response in animal models.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In this work, a phase II multicenter randomized double-blind clinical trial on COVID-19 patients was designed to evaluate the impact of the P2Et treatment on the clinical outcome and the immunological parameters related to the evolution of the disease. The Trial was registered with the number No. NCT04410510<jats:sup>*</jats:sup>. A complementary study in an animal model of lung fibrosis was carried out to evaluate <jats:italic>in situ</jats:italic> lung changes after P2Et <jats:italic>in vivo</jats:italic> administration. The ability of P2Et to inhibit the viral load of murine and human coronaviruses in cellular models was also evaluated.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Patients treated with P2Et were discharged on average after 7.4 days of admission vs. 9.6 days in the placebo group. Although a decrease in proinflammatory cytokines such as G-CSF, IL-15, IL-12, IL-6, IP10, MCP-1, MCP-2 and IL-18 was observed in both groups, P2Et decreased to a greater extent G-CSF, IL-6 and IL-18 among others, which are related to lower recovery of patients in the long term. The frequency of T lymphocytes (LT) CD3+, LT double negative (CD3+CD4-CD8-), NK cells increased in the P2Et group where the population of eosinophils was also significantly reduced. In the murine bleomycin model, P2Et also reduced lung inflammation and fibrosis. P2Et was able to reduce the viral replication of murine and human coronaviruses <jats:italic>in vitro</jats:italic>, showing its dual antiviral and anti-inflammatory role, key in disease control.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Taken together these results suggest that P2Et could be consider as a good co-adjuvant in the treatment of COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Clinical trail registration</jats:title><jats:p><jats:ext-link>https://clinicaltrials.gov/ct2/show/NCT04410510</jats:ext-link>, identifier: NCT04410510.</jats:p></jats:sec>", "alternative-id": [ "10.3389/fmed.2022.991873" ], "article-number": "991873", "author": [ { "affiliation": [], "family": "Urueña", "given": "Claudia", "sequence": "first" }, { "affiliation": [], "family": "Ballesteros-Ramírez", "given": "Ricardo", "sequence": "additional" }, { "affiliation": [], "family": "Gomez-Cadena", "given": "Alejandra", "sequence": "additional" }, { "affiliation": [], "family": "Barreto", "given": "Alfonso", "sequence": "additional" }, { "affiliation": [], "family": "Prieto", "given": "Karol", "sequence": "additional" }, { "affiliation": [], "family": "Quijano", "given": "Sandra", "sequence": "additional" }, { "affiliation": [], "family": "Aschner", "given": "Pablo", "sequence": "additional" }, { "affiliation": [], "family": "Martínez", "given": "Carlos", "sequence": "additional" }, { "affiliation": [], "family": "Zapata-Cardona", "given": "Maria I.", "sequence": "additional" }, { "affiliation": [], "family": "El-Ahanidi", "given": "Hajar", "sequence": "additional" }, { "affiliation": [], "family": "Jandus", "given": "Camilla", "sequence": "additional" }, { "affiliation": [], "family": "Florez-Alvarez", "given": "Lizdany", "sequence": "additional" }, { "affiliation": [], "family": "Rugeles", "given": "Maria Teresa", "sequence": "additional" }, { "affiliation": [], "family": "Zapata-Builes", "given": "Wildeman", "sequence": "additional" }, { "affiliation": [], "family": "Garcia", "given": "Angel Alberto", "sequence": "additional" }, { "affiliation": [], "family": "Fiorentino", "given": "Susana", "sequence": "additional" } ], "container-title": "Frontiers in Medicine", "container-title-short": "Front. Med.", "content-domain": { "crossmark-restriction": true, "domain": [ "frontiersin.org" ] }, "created": { "date-parts": [ [ 2022, 9, 8 ] ], "date-time": "2022-09-08T11:29:27Z", "timestamp": 1662636567000 }, "deposited": { "date-parts": [ [ 2022, 9, 8 ] ], "date-time": "2022-09-08T11:29:38Z", "timestamp": 1662636578000 }, "indexed": { "date-parts": [ [ 2025, 11, 14 ] ], "date-time": "2025-11-14T16:56:12Z", "timestamp": 1763139372662, "version": "3.41.2" }, "is-referenced-by-count": 10, "issued": { "date-parts": [ [ 2022, 9, 8 ] ] }, "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 9, 8 ] ], "date-time": "2022-09-08T00:00:00Z", "timestamp": 1662595200000 } } ], "link": [ { "URL": "https://www.frontiersin.org/articles/10.3389/fmed.2022.991873/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1965", "original-title": [], "prefix": "10.3389", "published": { "date-parts": [ [ 2022, 9, 8 ] ] }, "published-online": { "date-parts": [ [ 2022, 9, 8 ] ] }, "publisher": "Frontiers Media SA", "reference": [ { "DOI": "10.1016/j.phrs.2016.01.021", "article-title": "Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives", "author": "Dutra", "doi-asserted-by": "publisher", "first-page": "4", "journal-title": "Pharmacol Res.", "key": "B1", "volume": "112", "year": "2016" }, { "DOI": "10.1002/ptr.7008", "article-title": "Botanical drugs and supplements affecting the immune response in the time of COVID-19: implications for research and clinical practice", "author": "Brendler", "doi-asserted-by": "publisher", "first-page": "3013", "journal-title": "Phyther Res.", "key": "B2", "volume": "35", "year": "2021" }, { "DOI": "10.1067/mai.2003.17", "article-title": "Increased oxidative stress and altered levels of antioxidants in asthma", "author": "Nadeem", "doi-asserted-by": "publisher", "first-page": "72", "journal-title": "J Allergy Clin Immunol.", "key": "B3", "volume": "111", "year": "2003" }, { "DOI": "10.1016/0278-6915(96)00004-X", "article-title": "An evaluation of the antioxidant and antiviral action of extracts of rosemary and Provencal herbs", "author": "Aruoma", "doi-asserted-by": "publisher", "first-page": "449", "journal-title": "Food Chem Toxicol.", "key": "B4", "volume": "34", "year": "1996" }, { "DOI": "10.1177/2050312121991246", "article-title": "Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: a cross-sectional comparative study in Jigawa, Northwestern Nigeria", "author": "Muhammad", "doi-asserted-by": "publisher", "first-page": "2050312121991246", "journal-title": "SAGE Open Med.", "key": "B5", "volume": "9", "year": "2021" }, { "DOI": "10.1039/D0RA03774E", "article-title": "Natural products' role against COVID-19", "author": "da Silva Antonio", "doi-asserted-by": "publisher", "first-page": "23379", "journal-title": "RSC Adv.", "key": "B6", "volume": "10", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30183-5", "article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", "author": "Huang", "doi-asserted-by": "publisher", "first-page": "497", "journal-title": "Lancet.", "key": "B7", "volume": "395", "year": "2020" }, { "DOI": "10.1016/S1473-3099(20)30132-8", "article-title": "COVID-19: combining antiviral and anti-inflammatory treatments", "author": "Stebbing", "doi-asserted-by": "publisher", "first-page": "400", "journal-title": "Lancet Infect Dis.", "key": "B8", "volume": "20", "year": "2020" }, { "DOI": "10.1080/01635580903285098", "article-title": "Dietary polyphenols, inflammation, and cancer", "author": "Guo", "doi-asserted-by": "publisher", "first-page": "807", "journal-title": "Nutr Cancer.", "key": "B9", "volume": "61", "year": "2009" }, { "DOI": "10.1038/s41420-019-0214-2", "article-title": "Polyphenol-rich extract induces apoptosis with immunogenic markers in melanoma cells through the ER stress-associated kinase PERK", "author": "Prieto", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Cell death Discov.", "key": "B10", "volume": "5", "year": "2019" }, { "DOI": "10.1142/S0192415X16500956", "article-title": "Standardized extract from Caesalpinia spinosa is cytotoxic over cancer stem cells and enhance anticancer activity of doxorubicin", "author": "Sandoval", "doi-asserted-by": "publisher", "first-page": "1693", "journal-title": "Am J Chin Med.", "key": "B11", "volume": "44", "year": "2016" }, { "DOI": "10.3390/antiox9111105", "article-title": "Cell clearing systems as targets of polyphenols in viral infections: potential implications for COVID-19 pathogenesis", "author": "Limanaqi", "doi-asserted-by": "publisher", "first-page": "1105", "journal-title": "Antioxidants.", "key": "B12", "volume": "9", "year": "2020" }, { "DOI": "10.1186/1472-6882-13-74", "article-title": "Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model", "author": "Urueña", "doi-asserted-by": "publisher", "first-page": "74", "journal-title": "BMC Complement Altern Med.", "key": "B13", "volume": "13", "year": "2013" }, { "article-title": "Buenas prácticas clínicas: documento de las Américas", "key": "B14", "volume-title": "IV Conferencia Panamericana para la Armonización de la Reglamentación Farmacéutica", "year": "2005" }, { "DOI": "10.1001/jama.2013.281053", "article-title": "World medical association declaration of helsinki: ethical principles for medical research involving human subjects", "doi-asserted-by": "publisher", "first-page": "2191", "journal-title": "JAMA", "key": "B15", "volume": "310", "year": "2013" }, { "DOI": "10.1001/jama.2012.5669", "article-title": "Acute respiratory distress syndrome", "author": "Rubenfeld", "doi-asserted-by": "publisher", "first-page": "2526", "journal-title": "The Berlin Def JAMA.", "key": "B16", "volume": "307", "year": "2012" }, { "DOI": "10.1001/jama.2019.21118", "article-title": "Diagnosis and treatment of adults with community-acquired pneumonia", "author": "Olson", "doi-asserted-by": "publisher", "first-page": "885", "journal-title": "JAMA.", "key": "B17", "volume": "323", "year": "2020" }, { "DOI": "10.1001/jama.2016.0287", "article-title": "The third international consensus definitions for sepsis and septic shock (Sepsis-3)", "author": "Singer", "doi-asserted-by": "publisher", "first-page": "801", "journal-title": "JAMA.", "key": "B18", "volume": "315", "year": "2016" }, { "DOI": "10.22354/in.v24i3.852", "article-title": "Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia", "author": "Saavedra Trujillo", "doi-asserted-by": "publisher", "first-page": "186", "journal-title": "Infectio.", "key": "B19", "volume": "24", "year": "2020" }, { "DOI": "10.1016/j.toxrep.2020.12.024", "article-title": "Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from Caesalpinia spinosa", "author": "Ballesteros-Ramírez", "doi-asserted-by": "publisher", "first-page": "258", "journal-title": "Toxicol Rep.", "key": "B20", "volume": "8", "year": "2021" }, { "DOI": "10.1186/1472-6882-12-38", "article-title": "A gallotannin-rich fraction from Caesalpinia spinosa (Molina) Kuntze displays cytotoxic activity and raises sensitivity to doxorubicin in a leukemia cell line", "author": "Castañeda", "doi-asserted-by": "publisher", "first-page": "38", "journal-title": "BMC Complement Altern Med.", "key": "B21", "volume": "12", "year": "2012" }, { "key": "B22", "volume-title": "Botanical Drug Development Guidance for Industry", "year": "2016" }, { "article-title": "M3 (R2): Nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals", "key": "B23", "volume-title": "International conference on harmonization of technical requirements for the registration of pharmaceuticals for human use", "year": "2009" }, { "article-title": "Safety evaluation in healthy colombian volunteers of P2Et extract obtained from caesalpinia spinosa: design 3+ 3 phase i clinical trial", "author": "Duran", "first-page": "1", "key": "B24", "volume-title": "Evidence-Based Complement Altern Med", "year": "2022" }, { "key": "B25", "volume-title": "National Institutes of Health Common Terminology Criteria for Adverse Events (CTCAE)", "year": "2009" }, { "DOI": "10.3389/fmicb.2022.721103", "article-title": "Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro", "author": "Zapata-Cardona", "doi-asserted-by": "publisher", "first-page": "721103", "journal-title": "Front Microbiol.", "key": "B26", "volume": "13", "year": "2022" }, { "DOI": "10.3390/molecules26226900", "article-title": "Curcumin Inhibits invitro SARS-CoV-2 infection in vero E6 cells through multiple antiviral mechanisms", "author": "Marín-Palma", "doi-asserted-by": "publisher", "first-page": "6900", "journal-title": "Molecules.", "key": "B27", "volume": "26", "year": "2021" }, { "DOI": "10.1038/leu.2012.120", "article-title": "EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes", "author": "Van Dongen", "doi-asserted-by": "publisher", "first-page": "1908", "journal-title": "Leukemia.", "key": "B28", "volume": "26", "year": "2012" }, { "DOI": "10.1007/s10456-021-09805-6", "article-title": "COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects", "author": "Smadja", "doi-asserted-by": "publisher", "first-page": "755", "journal-title": "Angiogenesis.", "key": "B29", "volume": "24", "year": "2021" }, { "DOI": "10.3390/ijms22041737", "article-title": "Understanding viral infection mechanisms and patient symptoms for the development of COVID-19 therapeutics", "author": "Choi", "doi-asserted-by": "publisher", "first-page": "1737", "journal-title": "Int J Mol Sci.", "key": "B30", "volume": "22", "year": "2021" }, { "DOI": "10.1016/j.dsx.2021.102212", "article-title": "Elucidating causes of COVID-19 infection and related deaths after vaccination", "author": "Jain", "doi-asserted-by": "publisher", "first-page": "102212", "journal-title": "Diabetes Metab Syndr Clin Res Rev.", "key": "B31", "volume": "15", "year": "2021" }, { "DOI": "10.1152/ajpendo.00298.2020", "article-title": "Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?", "author": "Levy", "doi-asserted-by": "publisher", "first-page": "E689", "journal-title": "Am J Physiol Metab.", "key": "B32", "volume": "319", "year": "2020" }, { "DOI": "10.1038/s41467-021-21414-x", "article-title": "Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children", "author": "Neeland", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Nat Commun.", "key": "B33", "volume": "12", "year": "2021" }, { "DOI": "10.1038/s41591-020-0901-9", "article-title": "Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19", "author": "Liao", "doi-asserted-by": "publisher", "first-page": "842", "journal-title": "Nat Med.", "key": "B34", "volume": "26", "year": "2020" }, { "DOI": "10.4049/jimmunol.2001327", "article-title": "The inflammatory factors associated with disease severity to predict COVID-19 progression", "author": "Huang", "doi-asserted-by": "publisher", "first-page": "1597", "journal-title": "J Immunol.", "key": "B35", "volume": "206", "year": "2021" }, { "DOI": "10.3390/diseases4030026", "article-title": "Human coronaviruses: a review of virus–host interactions", "author": "Lim", "doi-asserted-by": "publisher", "first-page": "26", "journal-title": "Diseases.", "key": "B36", "volume": "4", "year": "2016" }, { "DOI": "10.4103/lungindia.lungindia_818_20", "article-title": "Post-COVID lung fibrosis: the tsunami that will follow the earthquake", "author": "Udwadia", "doi-asserted-by": "publisher", "first-page": "S41", "journal-title": "Lung India Off Organ Indian Chest Soc.", "key": "B37", "volume": "38", "year": "2021" }, { "DOI": "10.1084/jem.20161653", "article-title": "PD-1 regulates KLRG1+ group 2 innate lymphoid cells", "author": "Taylor", "doi-asserted-by": "publisher", "first-page": "1663", "journal-title": "J Exp Med.", "key": "B38", "volume": "214", "year": "2017" }, { "DOI": "10.1093/intimm/dxp102", "article-title": "IL-5-and eosinophil-mediated inflammation: from discovery to therapy", "author": "Kouro", "doi-asserted-by": "publisher", "first-page": "1303", "journal-title": "Int Immunol.", "key": "B39", "volume": "21", "year": "2009" }, { "DOI": "10.1067/mai.2000.109172", "article-title": "IL-9 expression by human eosinophils: regulation by IL-1β and TNF-α", "author": "Gounni", "doi-asserted-by": "publisher", "first-page": "460", "journal-title": "J Allergy Clin Immunol.", "key": "B40", "volume": "106", "year": "2000" }, { "DOI": "10.1159/000445215", "article-title": "A player and coordinator: the versatile roles of eosinophils in the immune system", "author": "Long", "doi-asserted-by": "publisher", "first-page": "96", "journal-title": "Transfus Med Hemotherapy.", "key": "B41", "volume": "43", "year": "2016" }, { "DOI": "10.4081/mrm.2021.758", "article-title": "Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells", "author": "Zahran", "doi-asserted-by": "publisher", "first-page": "758", "journal-title": "Multidiscip Respir Med.", "key": "B42", "volume": "16", "year": "2021" }, { "DOI": "10.3389/fimmu.2022.816005", "article-title": "CD3+ CD4-CD8-(Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer", "author": "Wu", "doi-asserted-by": "publisher", "first-page": "816005", "journal-title": "Front Immunol.", "key": "B43", "volume": "13", "year": "2022" }, { "DOI": "10.1038/mi.2015.91", "article-title": "Double-negative T resident memory cells of the lung react to influenza virus infection via CD11chi dendritic cells", "author": "Neyt", "doi-asserted-by": "publisher", "first-page": "999", "journal-title": "Mucosal Immunol.", "key": "B44", "volume": "9", "year": "2016" }, { "DOI": "10.1124/pharmrev.120.000063", "article-title": "Pharmacological modulation of immune responses by nutritional components", "author": "van Daal", "doi-asserted-by": "publisher", "first-page": "1369", "journal-title": "Pharmacol Rev.", "key": "B45", "volume": "73", "year": "2021" }, { "DOI": "10.3109/08923973.2010.522195", "article-title": "Catechin inhibits adhesion and migration of peripheral blood B cells by blocking CD11b", "author": "Kawai", "doi-asserted-by": "publisher", "first-page": "391", "journal-title": "Immunopharmacol Immunotoxicol.", "key": "B46", "volume": "33", "year": "2011" } ], "reference-count": 46, "references-count": 46, "relation": {}, "resource": { "primary": { "URL": "https://www.frontiersin.org/articles/10.3389/fmed.2022.991873/full" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et)", "type": "journal-article", "update-policy": "https://doi.org/10.3389/crossmark-policy", "volume": "9" }